Key Capital Management
BSX icon

Key Capital Management’s Boston Scientific BSX Stock Holding History

Key Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1K Buy
+23
New +$1.06K ﹤0.01% 680
2026
Q2 		– Sell
-23
Closed -$1.44K – 741
2026
Q1 		$1.44K Buy
+23
New +$1.84K ﹤0.01% 574

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Key Capital Management's BSX Position: Q3 2026 in Review

Key Capital Management opened a new position in Boston Scientific (BSX) in Q3 2026: 23 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #680 among its holdings. This is a return to the name: Key Capital Management previously reported a position in BSX as recently as Q1 2026.

Key Capital Management first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.44K in Q1 2026. 922 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Key Capital Management held 23 shares of Boston Scientific worth $1K as of Q3 2026.
  • Boston Scientific was a new Key Capital Management position in Q3 2026.
  • Boston Scientific made up ﹤0.01% of Key Capital Management's portfolio in Q3 2026, its #680 holding.
  • Key Capital Management first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Key Capital Management's Boston Scientific position peaked at $1.44K in Q1 2026.
  • 922 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.